• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for Clostridium difficile Infection.

作者信息

Fischer Monika, Kao Dina, Kassam Zain, Smith Justin, Louie Thomas, Sipe Brian, Torbeck Michelle, Xu Huiping, Ouyang Fangqian, Mozaffarian Dariush, Allegretti Jessica R

机构信息

Department of Gastroenterology, Indiana University School of Medicine, Indianapolis, Indiana.

Division of Gastroenterology, University of Alberta, Edmonton, AB, Canada.

出版信息

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1351-1353. doi: 10.1016/j.cgh.2017.12.007. Epub 2017 Dec 12.

DOI:10.1016/j.cgh.2017.12.007
PMID:29246701
Abstract
摘要

相似文献

1
Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for Clostridium difficile Infection.粪便捐献者的体重指数对艰难梭菌感染患者单次粪便微生物群移植后的受者体重无影响。
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1351-1353. doi: 10.1016/j.cgh.2017.12.007. Epub 2017 Dec 12.
2
Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.用于复发性艰难梭菌感染的粪便微生物群移植供体及粪便样本的实验室检测
J Clin Microbiol. 2017 Apr;55(4):1002-1010. doi: 10.1128/JCM.02327-16. Epub 2017 Jan 11.
3
Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.建立用于治疗艰难梭菌感染的粪便微生物群移植服务。
Clin Infect Dis. 2016 Apr 1;62(7):908-14. doi: 10.1093/cid/civ994. Epub 2015 Nov 30.
4
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.复发性艰难梭菌感染和/或溃疡性结肠炎患者单次供体粪便微生物群移植的纵向微生物组分析
PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018.
5
Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease.粪便移植会引发炎症性肠病吗？一项对31名患者进行的粪便移植病例系列研究，供体粪便后来被发现来自一名患克罗恩病的人。
Gut Microbes. 2017 May 4;8(3):205-207. doi: 10.1080/19490976.2017.1283469. Epub 2017 Jan 19.
6
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.造血干细胞移植受者复发性艰难梭菌感染的粪便微生物群移植
Transpl Infect Dis. 2016 Aug;18(4):628-33. doi: 10.1111/tid.12550. Epub 2016 Jul 5.
7
Fecal Microbiota Transplantation.粪便微生物群移植
Gastroenterol Clin North Am. 2017 Mar;46(1):171-185. doi: 10.1016/j.gtc.2016.09.012.
8
Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.粪菌移植治疗复发性艰难梭菌感染后抗菌药物耐药基因的获得和减少。
Clin Infect Dis. 2018 Jan 18;66(3):456-457. doi: 10.1093/cid/cix821.
9
Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?小肠细菌过度生长：在粪菌移植前评估中是否应该包括筛查？
Dig Dis Sci. 2018 Jan;63(1):193-197. doi: 10.1007/s10620-017-4864-8. Epub 2017 Nov 29.
10
Does the donor matter? Donor vs patient effects in the outcome of a next-generation microbiota-based drug trial for recurrent Clostridium difficile infection.供体重要吗？在一项基于下一代微生物群的复发性艰难梭菌感染药物试验结果中供体与患者的影响
Future Microbiol. 2016 May;11:611-6. doi: 10.2217/fmb.16.10. Epub 2016 Mar 17.

引用本文的文献

1
Body mass index changes after fecal microbiota transplantation for recurrent infection.粪便微生物群移植治疗复发性感染后体重指数的变化。
Therap Adv Gastroenterol. 2025 Feb 23;18:17562848251321121. doi: 10.1177/17562848251321121. eCollection 2025.
2
Fecal microbiota transplantation: current challenges and future landscapes.粪便微生物群移植：当前的挑战和未来的前景。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0006022. doi: 10.1128/cmr.00060-22. Epub 2024 May 8.
3
Questioning the foundations of the gut microbiota and obesity.质疑肠道微生物群和肥胖的基础。
Philos Trans R Soc Lond B Biol Sci. 2023 Oct 23;378(1888):20220221. doi: 10.1098/rstb.2022.0221. Epub 2023 Sep 4.
4
Liver-Gut-Interaction: Role of Microbiome Transplantation in the Future Treatment of Metabolic Disease.肝-肠相互作用：微生物群移植在代谢性疾病未来治疗中的作用。
J Pers Med. 2023 Jan 27;13(2):220. doi: 10.3390/jpm13020220.
5
Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols.非传染性疾病中的粪便微生物群移植：最新进展与方案
Front Med (Lausanne). 2022 Dec 8;9:1060581. doi: 10.3389/fmed.2022.1060581. eCollection 2022.
6
Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases.粪便微生物群移植作为人类疾病的新治疗途径。
J Clin Med. 2022 Jul 15;11(14):4119. doi: 10.3390/jcm11144119.
7
Safety of fecal microbiota transplantation for infection focusing on pathobionts and SARS-CoV-2.粪便微生物群移植治疗感染的安全性，重点关注致病共生菌和严重急性呼吸综合征冠状病毒2
Therap Adv Gastroenterol. 2021 Apr 21;14:17562848211009694. doi: 10.1177/17562848211009694. eCollection 2021.
8
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease.肠道微生物组和饮食在非酒精性脂肪性肝病发病机制中的作用。
Clin Mol Hepatol. 2021 Jan;27(1):22-43. doi: 10.3350/cmh.2020.0129. Epub 2020 Dec 10.
9
Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation.肠道微生物组在医学疾病中的异常表现和粪便微生物移植的潜在逆转作用。
Dig Dis Sci. 2020 Mar;65(3):741-756. doi: 10.1007/s10620-020-06102-y.
10
Establishing a donor stool bank for faecal microbiota transplantation: methods and feasibility.建立粪便微生物群移植供体粪便库：方法和可行性。
Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1837-1847. doi: 10.1007/s10096-019-03615-x. Epub 2019 Jul 4.